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LETTERS TO THE EDITORBICUSPID AORTOPATHY OR
BICUSPID AORTOPATHIES?
THE RISK IN GENERALIZING
To the Editor:
We read with interest the article by
Fazel and coworkers,1 which high-
lighted the previously underreported
issue of transverse aortic arch involve-
ment in aortopathy related to the bicus-
pid aortic valve (BAV). We totally
agree with the authors’ claim that the
surgical approach to BAV aortopathy
should be custom-tailored, inasmuch
as different morphologic patterns can
be encountered: this emerged also in
our recent study on 280 BAV sub-
jects.2 However, their conclusion in
favor of pre-emptive concomitant total
arch replacement for the majority of
BAV patients undergoing proximal
aortic operations may raise concerns.
In a recent large series,3 the dilata-
tion/aneurysm involved the arch in
only 4.3% of BAV patients, versus
7.3% without BAV. The anticipation
by Fazel’s group1 that a proximal
arch measuring 3.6 cm (as in ‘‘cluster
IV,’’ including 45% of the study pa-
tients) will dilate to 5 cm within 15
years after ascending aortic replace-
ment is not confirmed by clinical evi-
dence. The 1.9 mm/y growth rate that
they mention actually refers to the
mid-ascending tract,3 with the rate of
arch size progression currently being
unknown.
Unfortunately, this study lacks
a comparison with matched subjects
with a tricuspid aortic valve1: thus
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unique to the BAV setting, and the
definition itself of arch dilatation was
not done by comparison with normal
values. Moreover, as evident from
Figure 3,1 only cluster III (ascen-
dingþarch pattern) was quite homoge-
neous in terms of transverse arch
involvement, whereas many patients
in cluster IV (rootþascendingarch
pattern) actually had small arch dimen-
sions, in all comparable with those in
cluster I (root pattern) or II (ascending
pattern). However, the authors omitted
a statistical comparison of aortic
dimensions between clusters.
The BAV function and BAV mor-
phology factors should be considered
when trying to better discriminate
subgroups of BAV aortopathy. In the
Westhoff-Bleck magnetic resonance
imaging study,4 only BAV patients
with moderate–severe aortic regur-
gitation had significantly greater
transverse arch size compared with
matched controls, whereas in normally
functioning BAV patients only root
and ascending diameters were larger
than in controls. Schaefer and col-
leagues5 recently found right–left
orientation of the BAV cusps (right–
noncoronary fusion) to be associated
with a significantly larger proximal
arch compared with anteroposterior
orientation (right–left coronary fu-
sion). Interestingly, in Fazel’s report,
the highest prevalence of the right–
noncoronary pattern and the highest
mean grade of aortic insufficiency
were observed in cluster III. In our on-
going magnetic resonance imaging
study, 8 nonstenotic/nonregurgitant
BAV subjects with right–left coronary
fusion have been compared so far with
matched controls, showing no signifi-
cant difference in proximal (24.3 
2.8 cm vs 25.9  4.1; P ¼ .36) and
transverse arch size (20.5  2.3 cm
vs 22  3.1; P ¼ .29).
Different aortopathies may subtend
the various possible patterns of BAV-
related aortic dilatation: probably it is
not possible to issue general principles
and recommendations on such a com-d Cardiovascular Surgery c December 20plex and multifaceted matter. The
identification of a definite BAV phe-
notype representing a more ‘‘malig-
nant’’ form of disease, amenable to
more extensive surgical resections,
still requires special research efforts.
Alessandro Della Corte, MD
Maurizio Cotrufo, MD
Department of Cardiothoracic
Sciences
Second University of Naples
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We thank Della Corte and Cotrufo
from Naples for their interest in our
observations and for raising several
critical points concerning the ‘‘aortop-
athy’’ associated with bicuspid aortic
valve (BAV) disease. Owing to space
limitations, we can only discuss the
important question of extent of aortic
resection at the time of operation,
particularly in light of the recent con-
demnation of the more aggressive
American College of Cardiology/
American Heart Association guide-
lines by Guntheroth.108
Letters to the EditorPrimum non nocere. We agree with
this principle and uphold it in our clin-
ical practice. On all too numerous
occasions we have surgically treated
BAV patients who have undergone
previous aortic valve replacement
(AVR) with or without ascending
aortic replacement who present with
a large aortic arch aneurysm, pseudoa-
neurysm, or dissection, sometimes
annealed to the posterior table of the
sternum, which can mandate cooling
and circulatory arrest before complet-
ing the redo sternotomy. These are
challenging redo cases in the best of
hands. The situation might possibly
have been avoided if more complete
resection of the dilated aorta at the
time of initial procedure had been car-
ried out. Della Corte and Cotrufo over
the years have done a superb job de-
scribing the various histologic and
pathologic characterizations of the
aorta of patients with a BAV and
have highlighted that a diseased aorta
does not suddenly happen at the mag-
ical 5.0-cm mark. The 5.0-cm thresh-
old is just an arbitrary diameter at
which surgical results in average med-
ical centers are projected to be superior
to the natural history of the disease.
But here, as always, is the rub: Guide-
lines are easy to apply to medical ther-
apy, but application of guidelines to
different surgeons who have variable
degrees of experience with a given
procedure and substantially different
operative results may yield suboptimal
patient management.
It is difficult to know whether harm
has been done to a patient with BAV
disease with marked dilatation of the
ascending aorta and mild–moderate
involvement of the arch who only un-
derwent replacement of the ascending
aorta and AVR electively. Con-
versely, harm will be done if the
transverse arch is replaced in inexpe-
rienced centers when the arch dilata-
tion is only modest. However, this
raises the issue of who should do
these procedures in the first place. It
is clear from our and Westhoff-Bleck
and coworkers’ data2 that the aortop-The Journaathy of BAV disease extends into
the aortic arch in a large fraction of
patients with a BAV. We aim to pro-
vide a definitive surgical procedure at
the time of the initial operation, which
means complete resection of all weak
and dilated thoracic aortas. This is
justified by the facts outlined in our
report that the incremental surgical
risk to the patient is minimal or absent
in our hands.
Let us consider the following num-
bers published by Januzzi and co-
workers3 from the International
Registry of Aortic Dissection registry.
In their database, 68 patients were
younger than 40 years of age at the
time of aortic dissection; of these 68
patients, 9% had a BAV. Importantly,
12% of patients had had a previous
AVR at this young age. The aortic dis-
ease of those having undergone AVR
is not described. It is likely that the
majority of these patients had BAV
disease given that degenerative aortic
diseases are unlikely to present so
early and that patients with the Marfan
syndrome and severe aortic regurgita-
tion owing to annuloaortic ectasia
probably would have received full aor-
tic root replacement earlier. If indeed
this is the case, the majority of these
patients were harmed by not having
a complete resection of their diseased
aortas at the time of AVR. This notion
is supported by Borger and colleagues’
conclusion4 that leaving ascending
aortas of 4.5 to 5.0 cm in diameter at
the time of AVR for a BAV is danger-
ous and results in patient harm. More
telling are the data reported by Russo
and colleagues,5 who compared 50 pa-
tients with BAV to 50 similar patients
with a tricuspid valve (TAV) after
AVR. These patients were followed
up for a maximum of 27 years. Of
the 50 BAV patients, 7 suffered sud-
den death and 5 presented later with
acute aortic dissection. At the time of
presentation or follow-up, the mean
aortic diameter in the BAV group
was 4.6 cm. None of the TAV patients
sustained either complication. Al-
though the natural history of asymp-l of Thoracic and Cardiovascular Surgetomatic BAV patients treated
medically is relatively benign, as re-
cently reported by Michelena and
coworkers,6 it appears that surgically
referred patients, as might be antici-
pated, may have a more malignant
natural history.
In our patients with cluster IV aortic
dilatation, the average aortic diameter
was 3.6 cm at the takeoff of the in-
nominate artery; traditional clamping
of the aorta and replacement of the as-
cending aorta in such circumstances
would leave behind at least a 4.0-cm
diameter aorta extending into the
arch. In our minds, this is inadvisable
and may cause harm over the long
term. We believe that at a minimum
the surgeon should perform an open
distal anastomosis and resect some of
the dilated, soft aortic arch. Our pref-
erence includes a sigmoid-shaped
tailoring of the graft leaving only a nar-
row tongue of arch along the greater
curve and arch branches; this ‘‘penin-
sula style’’ arch replacement removes
almost the entire pathologic transverse
arch without resorting to an end-
to-end distal aortic anastomosis and
separate arch branch anastomoses.
With adequate preparation, moderate
hypothermia, and antegrade selective
cerebral perfusion, this has been
a safe and reproducible procedure in
our hands for nearly 10 years and
has been associated with very low
morbidity and mortality rates,
including stroke. It is unclear to us
why this approach is avoided by
many surgeons.
Given our experience, we continue
to argue for a more aggressive stance
regarding the aortopathy of BAV at
the initial operation. We also recog-
nize that simpler approaches might
be safer at other centers where many
dozens of arch replacements are not
done each year, and we would hope
that insightful surgeons would be hon-
est in discussing with their patients in-
dividual risk versus benefit in treating
this disease in his/her hands at his/her
institution. However, the surgeon
who leaves behind a substantialry c Volume 136, Number 6 1605
reported the case of a female patient
with an intrapericardial bronchogenic
cyst compressing the left main coro-
nary artery who had acute severe
coronary ischemia. Two weeks post-
operatively a magnetic resonance im-
aging (MRI) study showed another
cyst in the subcarinal position not
compressing the nearby structures but
requiring a second operation.
Bronchogenic cysts account for
6% to 15% of primary mediastinal
masses.2 These lesions are usually de-
tected incidentally by chest radiogra-
phy or computed tomograpphy (CT),
but in some cases they could present
as an emergency, life-threatening situ-
ation.3 Symptoms of intrapericardial
bronchogenic cysts can vary with the
location and size of the mass and
with the compression on the heart
and vessels. If symptoms such as chest
pain, shortness of breath, and arrhyth-
mias are present, it is important to con-
sider this rare entity in the differential
diagnosis with coronary ischemia.2
Echocardiography and transesopha-
geal echocardiography (TEE) are
usually used to assess cardiac and
paracardiac lesions.2,3 However, CT
allows an accurate study of these le-
sions and above all their topographic
relationship in order to plan the most
appropriate surgical approach.4,5 MRI
may also play a role when differential
diagnosis from other mediastinal
masses is difficult.3,5
For an accurate interpretation of this
case study, it would be important to
examine the following three questions:
1. In Figure 1 the authors affirm that
the coronary angiogram showed se-
vere compression of the ostium of
have been better to check the pa-
tency of the left coronary artery
after cyst removal?
In the discussion section the authors
assert that the etiology of the mass was
uncertain, but in our opinion this does
not justify the bypass, especially
because the coronary anatomy was
normal.
3. Finally, we believe that the second
cyst (sized 5 3 3 cm) was large
enough to have been detected by
the perioperative TEE, avoiding
the second operation.
Actually, the thoracic CT and the
endoscopic ultrasound allow the sur-
geon to have a correct preoperative
diagnosis in the mediastinal lesions
to use the most appropriate surgical
approach.5
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Letters to the Editorsegment of dilated, abnormal aorta at
the time of the first operation in a pa-
tient with BAV disease should recog-
nize that he or she has most likely
performed—for whatever reason—an
incomplete procedure, something E.
Stanley Crawford, MD, told us over
20 years ago was the ‘‘great surgical
sin of omission.’’
Shafie S. Fazel, MD, PhD
D. Craig Miller, MD
Department of Cardiothoracic
Surgery
Stanford University Medical School
Stanford, Calif
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